Published in Gynecol Oncol on December 01, 2000
Cytoreductive surgery and intraperitoneal chemo-hyperthermia for chemo-resistant and recurrent advanced epithelial ovarian cancer: prospective study of 81 patients. World J Surg (2007) 1.66
A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival. Proc Natl Acad Sci U S A (2006) 1.52
Maximal cytoreductive effort in epithelial ovarian cancer surgery. J Gynecol Oncol (2010) 1.11
Treatment for recurrent ovarian cancer-at first relapse. J Oncol (2009) 1.08
Ovarian cancer: the duplicity of CA125 measurement. Nat Rev Clin Oncol (2010) 1.01
Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer. Cochrane Database Syst Rev (2010) 0.88
Quaternary cytoreductive surgery in ovarian cancer: does surgical effort still matter? Br J Cancer (2013) 0.82
The role of secondary surgery in recurrent ovarian cancer. Int J Surg Oncol (2012) 0.81
Loss of autophagy-related protein Beclin 1 may define poor prognosis in ovarian clear cell carcinomas. Int J Oncol (2015) 0.79
The role of secondary cytoreductive surgery in patients with recurrent epithelial ovarian, tubal, and peritoneal cancers: a comparative effectiveness analysis. Oncologist (2012) 0.78
Survival Impact of Secondary Cytoreductive Surgery for Recurrent Ovarian Cancer in an Asian Population. Oman Med J (2015) 0.75
Hypertrophic cardiomyopathy: is a left ventricular outflow tract gradient a major prognostic determinant? Eur Heart J (1990) 1.73
A comparison of ultrasonography and magnetic resonance imaging in the evaluation of temporomandibular joint involvement in rheumatoid arthritis and psoriatic arthritis. Rheumatology (Oxford) (2003) 1.61
Uterine leiomyosarcoma: analysis of treatment failures and survival. Gynecol Oncol (1996) 1.58
Fine needle aspiration cytopathology of phyllodes tumor. Differential diagnosis with fibroadenoma. Acta Cytol (1988) 1.57
Cyclin D1 overexpression in thyroid carcinomas: relation with clinico-pathological parameters, retinoblastoma gene product, and Ki67 labeling index. Thyroid (2000) 1.52
Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study. Gynecol Oncol (2001) 1.51
Nonrecurrent laryngeal nerve predicted before thyroidectomy by preoperative imaging. J Am Coll Surg (2000) 1.46
Endometrial stromal sarcoma: analysis of treatment failures and survival. Gynecol Oncol (1996) 1.39
Inadvertent tracheal perforation during thyroidectomy (Br J Surg 2006; 93: 55-56). Br J Surg (2006) 1.23
p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study. Br J Cancer (1997) 1.21
Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature. Int J Gynecol Cancer (2007) 1.20
Surgical treatment of Graves' disease: subtotal or total thyroidectomy? Surgery (1996) 1.17
N-ras mutation in poorly differentiated thyroid carcinomas: correlation with bone metastases and inverse correlation to thyroglobulin expression. Thyroid (2000) 1.14
Serum half-life of CA 125 during early chemotherapy as an independent prognostic variable for patients with advanced epithelial ovarian cancer: results of a multicentric Italian study. Gynecol Oncol (1995) 1.12
Endogenous androgens and carotid intimal-medial thickness in women. J Clin Endocrinol Metab (1999) 1.10
Role of neck ultrasonography in the follow-up of patients operated on for thyroid cancer. Thyroid (1995) 1.08
Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study). Int J Gynecol Cancer (2007) 1.04
Parotid sialography and minor salivary gland biopsy in the diagnosis of Sjögren's syndrome. A comparative study of 84 patients. J Rheumatol (1988) 1.03
The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases. Eur J Gynaecol Oncol (2002) 1.03
Association of Mycobacterium tuberculosis complex isolates of BOVIS and Central Asian (CAS) genotypic lineages with extrapulmonary disease. Clin Microbiol Infect (2009) 1.02
Ankyloglossia: a morphofunctional investigation in children. Oral Dis (2005) 1.01
Analysis of the pattern of hypersensitivity reactions in patients receiving carboplatin retreatment for recurrent ovarian cancer. Int J Gynecol Cancer (2008) 1.00
Assessment of the prognostic relevance of serum anti-p53 antibodies in epithelial ovarian cancer. Gynecol Oncol (1999) 1.00
The relationship between postoperative decline of serum CA 125 levels and size of residual disease after initial surgery in patients with advanced ovarian cancer: a CTF study. Gynecol Oncol (1996) 0.97
Mediastinal goitres: when the transthoracic approach? Acta Chir Belg (2001) 0.95
Regional lymph node dissection in the treatment of renal cell carcinoma: is it useful in patients with no suspected adenopathy before or during surgery? BJU Int (2001) 0.95
Preoperative localization of suspicious parathyroid adenomas by assay of parathyroid hormone in needle aspirates. Eur J Endocrinol (1998) 0.95
Vagal paragangliomas: two case reports. Acta Otorhinolaryngol Ital (2007) 0.94
Sixty adrenal masses of large dimensions: hormonal and morphologic evaluation. Urology (1998) 0.94
Epidoxorubicin and lonidamine in refractory or recurrent epithelial ovarian cancer. Eur J Cancer (1994) 0.92
Role of frozen section associated with intraoperative cytology in comparison to FNA and FS alone in the management of thyroid nodules. Eur J Surg Oncol (2007) 0.91
Long-term survival in medically treated patients with ischaemic heart disease and prognostic importance of clinical and electrocardiographic data (the Italian CNR Multicentre Prospective Study OD1). Eur Heart J (1989) 0.91
Comparison among sonography, double-tracer subtraction scintigraphy, and double-phase scintigraphy in the detection of parathyroid lesions. AJR Am J Roentgenol (1996) 0.90
The course of Graves' ophthalmopathy is not influenced by near total thyroidectomy: a case-control study. Clin Endocrinol (Oxf) (1999) 0.90
Endoscopic thyroid and parathyroid surgery. Surg Endosc (1999) 0.90
Angiogenesis in human normal and pathologic adrenal cortex. J Clin Endocrinol Metab (2002) 0.90
[Thyroid carcinoma in a thyroglossal duct cyst: tumor resection alone or a total thyroidectomy?]. Ann Chir (1998) 0.90
Analysis of failures after negative second-look in patients with advanced ovarian cancer: an Italian multicenter study. Gynecol Oncol (1998) 0.89
Behaviour of von Willebrand factor antigen in follow-up of polymyalgia rheumatica/giant cell arteritis. Scand J Rheumatol (1988) 0.88
Influence of endogenous androgens on carotid wall in postmenopausal women. Menopause (2001) 0.88
Serum anti-p53 antibodies in the follow-up of patients with advanced ovarian carcinoma. Anticancer Res (1999) 0.87
Molecular mechanisms of apoptosis and chemosensitivity to platinum and paclitaxel in ovarian cancer: biological data and clinical implications. Eur J Gynaecol Oncol (2002) 0.87
Nutraceutical value and safety of tomato fruits produced by mycorrhizal plants. Br J Nutr (2011) 0.86
Determinants of end-stage idiopathic dilated cardiomyopathy: a multivariate analysis of 104 patients. Clin Cardiol (1989) 0.86
Adrenal masses in non-small cell lung carcinoma patients: is there any role for laparoscopic procedures? J Laparoendosc Adv Surg Tech A (1998) 0.86
Plasma C-reactive protein in hemodialysis patients: a cross-sectional, longitudinal clinical survey. Blood Purif (2000) 0.86
A comparison of pretreatment serum levels of four tumor markers in patients with endometrial and cervical carcinoma. Eur J Gynaecol Oncol (1990) 0.85
Total parathyroidectomy without autotransplantation for the treatment of secondary hyperparathyroidism associated with chronic kidney disease: clinical and laboratory long-term follow-up. Biomed Pharmacother (2009) 0.85
Traditional versus laparoscopic surgery in the treatment of pheochromocytoma: a preliminary study. J Laparoendosc Adv Surg Tech A (1997) 0.85
Preoperative serum antibodies against the p53 protein in patients with ovarian and endometrial cancer. Anticancer Res (1997) 0.85
Accuracy of cervical/vaginal cytology in the diagnosis of bacterial vaginosis. Sex Transm Dis (1998) 0.84
Preoperative serum E-cadherin assay in patients with ovarian carcinoma. Anticancer Res (1999) 0.84
Malnutrition and cachexia in ovarian cancer patients: pathophysiology and management. Anticancer Res (2001) 0.84
Serum preoperative vascular endothelial growth factor (VEGF) in epithelial ovarian cancer: relationship with prognostic variables and clinical outcome. Anticancer Res (1999) 0.84
The clinical relevance of serum CYFRA 21-1 assay in patients with ovarian cancer. Int J Gynecol Cancer (2001) 0.83
Effect of plasma metformin concentrations on serum lipid levels in type II diabetic patients. Acta Diabetol Lat (1988) 0.83
Blood viscosity and filtration abnormalities in mixed cryoglobulinemia patients. Clin Exp Rheumatol (1990) 0.83
First-line chemotherapy with epidoxorubicin, paclitaxel, and carboplatin for the treatment of advanced epithelial ovarian cancer patients. Gynecol Oncol (2003) 0.82
A 4-year evaluation of toxoplasmosis seroprevalence in the general population and in women of reproductive age in central Italy. Epidemiol Infect (2012) 0.82
Disappearance rate of serum calcitonin after total thyroidectomy for medullary thyroid carcinoma. Int J Biol Markers (1994) 0.82
Predictors of sudden death in idiopathic dilated cardiomyopathy. Am J Cardiol (1989) 0.81
Evaluation of the 1997 tumour, nodes and metastases classification of renal cell carcinoma: experience in 172 patients. BJU Int (2000) 0.81
Apoptosis control and proliferation marker in human normal and neoplastic adrenocortical tissues. Br J Cancer (2002) 0.81
Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer. Anticancer Res (2000) 0.81
Salivary immunoreactive insulin: a new entry in clinical chemistry? Clin Chem (1988) 0.81
Sex-steroid hormones, gonadotropin and ovarian carcinogenesis: a review of epidemiological and experimental data. Gynecol Endocrinol (2004) 0.81
p53 status is neither a predictive nor a prognostic variable in patients with advanced ovarian cancer treated with a paclitaxel-based regimen. Anticancer Res (2001) 0.81
Oxidative and genotoxic damage after radio-iodine therapy of Graves' hyperthyroidism. Int J Radiat Biol (2004) 0.81
Proteomic analysis of human thyroid fine needle aspiration fluid. J Endocrinol Invest (2007) 0.81
Thyroid carcinoma in intrathoracic goiter. Langenbecks Arch Surg (1998) 0.80
Sonographic appearance of ARDS. Letter: ref. Tsubo T, Yatsu Y, Suzuki A, Iwakawa T, Okawa H, Ishihara H, Matsuki A (2001). Daily changes of the area of density in the dependent lung region--evaluation using transesophageal echocardiography. Intensive Care Med 27:1881-1886. Intensive Care Med (2002) 0.80
Early treatment of hereditary medullary thyroid carcinoma after attribution of multiple endocrine neoplasia type 2 gene carrier status by screening for ret gene mutations. Surgery (1995) 0.80
Conn syndrome: 14 year's experience from two European centres. Eur J Surg (1998) 0.79
Preoperative D-dimer plasma assay is not a predictor of clinical outcome for patients with advanced ovarian cancer. Gynecol Oncol (1997) 0.79
Is pretreatment hemoglobin level a predictor of complete response to salvage chemotherapy for recurrent platinum-pretreated ovarian carcinoma? Eur J Gynaecol Oncol (2003) 0.79
An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer. Anticancer Res (2000) 0.79
Serum CA125 assay in the early diagnosis of recurrent epithelial ovarian cancer. Oncol Rep (1996) 0.79
[Digital videoradiography applied to the study of the recto-anal region during defecography]. Radiol Med (1991) 0.78
Serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant v5 (sCD44-v5), and CD44 splice variant v6 (sCD44-v6) in patients with epithelial ovarian cancer. Anticancer Res (1998) 0.78